Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis

ACS Nano

Volumn 5, Issue 9, 2011, Pages 7155-7167

  Tenzer, Stefan ^a   Docter, Dominic ^b   Rosfa, Susanne ^a   Wlodarski, Alexandra ^a   Kuharev, Jörg ^a   Rekik, Alexander ^b   Knauer, Shirley K ^c   Bantz, Christoph ^a   Nawroth, Thomas ^a   Bier, Carolin ^b   Sirirattanapan, Jarinratn ^b,d   Mann, Wolf ^b   Treuel, Lennart ^e   Zellner, Reinhard ^e   Maskos, Michael ^a,f   Schild, Hansjörg ^a   Stauber, Roland H ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^d SRINAKHARINWIROT UNIVERSITY   (Thailand)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f Division 63 Durability of Polymers   (Germany)

Author keywords

bioinformatics; bionanoscience; colloidal chemistry; immunology; liquid chromatography mass spectrometry; nanomedicine; nanotoxicity

Indexed keywords

BIONANOSCIENCE; COLLOIDAL CHEMISTRY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; NANOMEDICINES; NANOTOXICITY;

BIOINFORMATICS; BLOOD; COAGULATION; ELECTROPHORESIS; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; PARTICLE SIZE ANALYSIS; PLASMAS; SILICA;

PROTEINS;

NANOPARTICLE;

ARTICLE; HUMAN; MASS SPECTROMETRY; PARTICLE SIZE; PLASMA; PROTEOMICS;

HUMANS; MASS SPECTROMETRY; NANOPARTICLES; PARTICLE SIZE; PLASMA; PROTEOMICS;

EID: 80053328840     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn201950e     Document Type: Article

References (58)

1. Riehemann, K.; Schneider, S. W.; Luger, T. A.; Godin, B.; Ferrari, M.; Fuchs, H. Nanomedicine - Challenge and Perspectives Angew. Chem., Int. Ed. 2009, 48, 872-897
2. McNeil, S. E. Nanoparticle Therapeutics A Personal Perspective Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009, 1, 264-271
3. Murday, J. S.; Siegel, R. W.; Stein, J.; Wright, J. F. Translational Nanomedicine: Status Assessment and Opportunities Nanomedicine 2009, 5, 251-273
4. Ferrari, M. Nanogeometry: Beyond Drug Delivery Nat. Nanotechnol. 2008, 3, 131-132 (Pubitemid 351355138)
5. Qian, X.; Peng, X. H.; Ansari, D. O.; Yin-Goen, Q.; Chen, G. Z.; Shin, D. M.; Yang, L.; Young, A. N.; Wang, M. D.; Nie, S. In Vivo Tumor Targeting and Spectroscopic Detection with Surface-Enhanced Raman Nanoparticle Tags Nat. Biotechnol. 2008, 26, 83-90
6. Alexiou, C.; Schmid, R. J.; Jurgons, R.; Kremer, M.; Wanner, G.; Bergemann, C.; Huenges, E.; Nawroth, T.; Arnold, W.; Parak, F. G. Targeting Cancer Cells: Magnetic Nanoparticles as Drug Carriers Eur. Biophys. J. 2006, 35, 446-450
7. Leszczynski, J. Bionanoscience: Nano Meets Bio at the Interface Nat. Nanotechnol. 2010, 5, 633-634
8. Adiseshaiah, P. P.; Hall, J. B.; McNeil, S. E. Nanomaterial Standards for Efficacy and Toxicity Assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2, 99-112
9. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K. A.; Linse, S. Understanding the Nanoparticle-Protein Corona Using Methods to Quantify Exchange Rates and Affinities of Proteins for Nanoparticles Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 2050-2055 (Pubitemid 46391350)
10. Lynch, I.; Cedervall, T.; Lundqvist, M.; Cabaleiro-Lago, C.; Linse, S.; Dawson, K. A. The Nanoparticle-Protein Complex as a Biological Entity; a Complex Fluids and Surface Science Challenge for the 21st Century. Adv. Colloid Interface Sci. 2007, not supplied.
11. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A. What the Cell "Sees" in Bionanoscience J. Am. Chem. Soc. 2010, 132, 5761-5768
12. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 14265-14270
13. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle Interaction with Plasma Proteins as It Relates to Particle Biodistribution, Biocompatibility and Therapeutic Efficacy Adv. Drug Delivery Rev. 2009, 61, 428-437
14. Verma, A.; Stellacci, F. Effect of Surface Properties on Nanoparticle-Cell Interactions Small 2010, 6, 12-21
15. Farrah, T.; Deutsch, E. W.; Omenn, G. S.; Campbell, D. S.; Sun, Z.; Bletz, J. A.; Mallick, P.; Katz, J. E.; Malmstrom, J.; Ossola, R. etal. A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in Peptideatlas. Mol Cell Proteomics 2011, not supplied.
16. Jeong, S. K.; Kwon, M. S.; Lee, E. Y.; Lee, H. J.; Cho, S. Y.; Kim, H.; Yoo, J. S.; Omenn, G. S.; Aebersold, R.; Hanash, S. et al. Biomarkerdigger: A Versatile Disease Proteome Database and Analysis Platform for the Identification of Plasma Cancer Biomarkers Proteomics 2009, 9, 3729-3740
17. Lacerda, S. H.; Park, J. J.; Meuse, C.; Pristinski, D.; Becker, M. L.; Karim, A.; Douglas, J. F. Interaction of Gold Nanoparticles with Common Human Blood Proteins ACS Nano 2011, 4, 365-379
18. Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S. C.; Cagney, G.; Linse, S.; Dawson, K. A. Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles Angew. Chem., Int. Ed. 2007, 46, 5754-5756 (Pubitemid 47172204)
19. Hortin, G. L.; Sviridov, D.; Anderson, N. L. High-Abundance Polypeptides of the Human Plasma Proteome Comprising the Top 4 Logs of Polypeptide Abundance Clin Chem 2008, 54, 1608-1616
20. Omenn, G. S. Data Management and Data Integration in the Hupo Plasma Proteome Project Methods Mol. Biol. 2011, 696, 247-257
21. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface Nat. Mater. 2009, 8, 543-557
22. Dobrovolskaia, M. A.; Clogston, J. D.; Neun, B. W.; Hall, J. B.; Patri, A. K.; McNeil, S. E. Method for Analysis of Nanoparticle Hemolytic Properties in Vitro Nano Lett 2008, 8, 2180-2187
23. Dobrovolskaia, M. A.; McNeil, S. E. Immunological Properties of Engineered Nanomaterials Nat. Nanotechnol. 2007, 2, 469-478 (Pubitemid 47220069)
24. Xia, T.; Li, N.; Nel, A. E. Potential Health Impact of Nanoparticles Annu. Rev. Public Health 2009, 30, 137-150
25. Lynch, I.; Salvati, A.; Dawson, K. A. Protein-Nanoparticle Interactions: What Does the Cell See? Nat. Nanotechnol. 2009, 4, 546-547
26. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J. D.; Ayub, N.; Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E. Interaction of Colloidal Gold Nanoparticles with Human Blood: Effects on Particle Size and Analysis of Plasma Protein Binding Profiles Nanomedicine 2009, 5, 106-117
27. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E. Preclinical Studies to Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution Mol. Pharm. 2008, 5, 487-495
28. Mahmoudi, M.; Lynch, I.; Ejtehadi, M. R.; Monopoli, M. P.; Bombelli, F. B.; Laurent, S. Protein-Nanoparticle Interactions: Opportunities and Challenges. Chem. Rev. 2011, DOI: 10.1021/cr100440g.
29. Klein, J. Probing the Interactions of Proteins and Nanoparticles Proc. Natl. Acad. Sci. U. S. A. 2007, 104, 2029-2030 (Pubitemid 46391345)
30. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles J. Am. Chem. Soc. 2011, 133, 2525-2534
31. Gessner, A.; Lieske, A.; Paulke, B. R.; Muller, R. H. Functional Groups on Polystyrene Model Nanoparticles: Influence on Protein Adsorption J. Biomed. Mater. Res. A 2003, 65, 319-326 (Pubitemid 37517267)
32. Rocker, C.; Potzl, M.; Zhang, F.; Parak, W. J.; Nienhaus, G. U. A Quantitative Fluorescence Study of Protein Monolayer Formation on Colloidal Nanoparticles Nat. Nanotechnol. 2009, 4, 577-580
33. Deng, Z. J.; Mortimer, G.; Schiller, T.; Musumeci, A.; Martin, D.; Minchin, R. F. Differential Plasma Protein Binding to Metal Oxide Nanoparticles Nanotechnology 2009, 20, 455101
34. Min, Y. J.; Akbulut, M.; Kristiansen, K.; Golan, Y.; Israelachvili, J. The Role of Interparticle and External Forces in Nanoparticle Assembly Nat. Mater. 2008, 7, 527-538
35. Treuel, L.; Malissek, M.; Gebauer, J. S.; Zellner, R. The Influence of Surface Composition of Nanoparticles on Their Interactions with Serum Albumin Chemphyschem 2010, 11, 3093-3099
36. Gessner, A.; Lieske, A.; Paulke, B.; Muller, R. Influence of Surface Charge Density on Protein Adsorption on Polymeric Nanoparticles: Analysis by Two-Dimensional Electrophoresis Eur. J. Pharm. Biopharm. 2002, 54, 165-170 (Pubitemid 34919390)
37. Dobrovolskaia, M. A.; Germolec, D. R.; Weaver, J. L. Evaluation of Nanoparticle Immunotoxicity Nat. Nanotechnol. 2009, 4, 411-414
38. Radomski, A.; Jurasz, P.; Alonso-Escolano, D.; Drews, M.; Morandi, M.; Malinski, T.; Radomski, M. W. Nanoparticle-Induced Platelet Aggregation and Vascular Thrombosis Br. J. Pharmacol. 2005, 146, 882-893 (Pubitemid 41622255)
39. Vaisar, T.; Pennathur, S.; Green, P. S.; Gharib, S. A.; Hoofnagle, A. N.; Cheung, M. C.; Byun, J.; Vuletic, S.; Kassim, S.; Singh, P. Shotgun Proteomics Implicates Protease Inhibition and Complement Activation in the Antiinflammatory Properties of Hdl J. Clin. Invest. 2007, 117, 746-756 (Pubitemid 46348533)
40. Reilly, M. P.; Tall, A. R. Hdl Proteomics: Pot of Gold or Pandora's Box? J. Clin. Invest. 2007, 117, 595-598 (Pubitemid 46348516)
41. Hellstrand, E.; Lynch, I.; Andersson, A.; Drakenberg, T.; Dahlback, B.; Dawson, K. A.; Linse, S.; Cedervall, T. Complete High-Density Lipoproteins in Nanoparticle Corona FEBS J. 2009, 276, 3372-3381
42. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Buchel, C.; Kreuter, J. Human Serum Albumin Nanoparticles Modified with Apolipoprotein a-I Cross the Blood-Brain Barrier and Enter the Rodent Brain J. Drug Targeting 2010, 18, 842-848
43. Benderly, M.; Boyko, V.; Goldbourt, U. Apolipoproteins and Long-Term Prognosis in Coronary Heart Disease Patients Am. Heart J. 2009, 157, 103-110
44. Thambisetty, M.; Simmons, A.; Velayudhan, L.; Hye, A.; Campbell, J.; Zhang, Y.; Wahlund, L. O.; Westman, E.; Kinsey, A.; Guntert, A. et al. Association of Plasma Clusterin Concentration with Severity, Pathology, and Progression in Alzheimer Disease Arch. Gen. Psychiatry 2010, 67, 739-748
45. Bucki, R.; Levental, I.; Kulakowska, A.; Janmey, P. A. Plasma Gelsolin: Function, Prognostic Value, and Potential Therapeutic Use Curr. Protein Pept. Sci. 2008, 9, 541-551
46. DiNubile, M. J. Plasma Gelsolin as a Biomarker of Inflammation Arthritis Res. Ther. 2008, 10, 124
47. Spinardi, L.; Witke, W. Gelsolin and Diseases Subcell Biochem. 2007, 45, 55-69
48. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time Evolution of the Nanoparticle Protein Corona ACS Nano 2010, 4, 3623-3632
49. Dell'Orco, D.; Lundqvist, M.; Oslakovic, C.; Cedervall, T.; Linse, S. Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid PLoS One 2010, 5, e10949
50. Jiang, X.; Weise, S.; Hafner, M.; Rocker, C.; Zhang, F.; Parak, W. J.; Nienhaus, G. U. Quantitative Analysis of the Protein Corona on Fept Nanoparticles Formed by Transferrin Binding J. R. Soc. Interface 2010, 7 (Suppl 1) S5-S13
51. Moreau, J. W.; Weber, P. K.; Martin, M. C.; Gilbert, B.; Hutcheon, I. D.; Banfield, J. F. Extracellular Proteins Limit the Dispersal of Biogenic Nanoparticles Science 2007, 316, 1600-1603 (Pubitemid 46982029)
52. Kasper, J.; Hermanns, I.; Bantz, C.; Maskos, M.; Stauber, R. H.; Pohl, C.; Unger, R.; Kirkpatrick, J. C. Inflammatory and Cytotoxic Responses of an Alveolar-Capillary Coculture Model to Silica Nanoparticles: Comparison with Conventional Monocultures Particle Fiber Toxicol. 2011, 8, 1-16
53. Scherer, C.; Noskov, S.; Utech, S.; Bantz, C.; Mueller, W.; Krohne, K.; Maskos, M. Characterization of Polymer Nanoparticles by Asymmetrical Flow Field Flow Fractionation (Af-Fff) J. Nanosci. Nanotechnol. 2010, 10, 6834-6839
54. Bier, C.; Knauer, S. K.; Klapthor, A.; Schweitzer, A.; Rekik, A.; Kramer, O. H.; Marschalek, R.; Stauber, R. H. Cell-Based Analysis of Structure-Function Activity of Threonine Aspartase 1 J. Biol. Chem. 2011, 286, 3007-3017
55. Thiel, U. J.; Feltens, R.; Adryan, B.; Gieringer, R.; Brochhausen, C.; Schuon, R.; Fillies, T.; Grus, F.; Mann, W. J.; Brieger, J. Analysis of Differentially Expressed Proteins in Oral Squamous Cell Carcinoma by Maldi-Tof Ms J. Oral Pathol. Med. 2010, 40, 369-379
56. Tenzer, S.; Wee, E.; Burgevin, A.; Stewart-Jones, G.; Friis, L.; Lamberth, K.; Chang, C. H.; Harndahl, M.; Weimershaus, M.; Gerstoft, J. et al. Antigen Processing Influences Hiv-Specific Cytotoxic T Lymphocyte Immunodominance Nat. Immunol. 2009, 10, 636-646
57. Silva, J. C.; Gorenstein, M. V.; Li, G. Z.; Vissers, J. P.; Geromanos, S. J. Absolute Quantification of Proteins by Lcmse: A Virtue of Parallel Ms Acquisition Mol. Cell Proteomics 2006, 5, 144-156 (Pubitemid 43169347)
58. Knauer, S. K.; Heinrich, U. R.; Bier, C.; Habtemichael, N.; Docter, D.; Helling, K.; Mann, W. J.; Stauber, R. H. An Otoprotective Role for the Apoptosis Inhibitor Protein Survivin Cell Death Dis. 2010, 1, e51